Morning Movers Gapping up $ユナイテッド・エアラインズ・ホールディングス(UAL.US)$stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel. $アボットラボラトリーズ(ABT.US)$stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
$アボットラボラトリーズ(ABT.US)$ Introduction On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Insiders selling shares with no recorded purchases over the last year could worry investors. Despite high insider ownership, recent selling activity suggests insiders don't see shares as a bargain.
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
Analysts' outlook on Abbott Laboratories remains steady, despite projected slowdown in revenue growth to 4.6% annually until 2024, well below its historical 7.9% p.a. growth and slower than industry peers.
Despite strong earnings per share growth, the market seems pessimistic about the company. Dividends paid have boosted total shareholder return, suggesting the company's performance remains strong even as share price gains slow.
Abbott is shifting focus from the dwindling COVID testing sector to its core segments, banking on products like continuous glucose monitors for future growth. The company also sees potential in the rising popularity of anti-obesity medications.
Morning Movers Gapping up $ネットフリックス(NFLX.US)$stock rose 9.4% after the streaming giant reported the addition of far more paying subscribers in the fourth quarter than expected, helped by a slate of popular programming. $テスラ(TSLA.US)$stock rose 1.3% after the EV manufacturer following a Reuters report which stated the company has informed suppliers it wants to start production of a new mass-market electric vehicle in mid-2025...
アボットラボラトリーズに関するコメント
コラムToday's Morning Movers and Top Ratings: ASML, LLY, ADSK, UAL and More
Gapping up
$ユナイテッド・エアラインズ・ホールディングス(UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$アボットラボラトリーズ(ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
コラムPreview of Abbott's Q1 performance: The COVID-19 pandemic dividend dissipates, and cost pressures increase
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Abbott shares slip as first-quarter earnings outlook misses estimates
Read more here: Abbott Shares Slip as First-Quarter Earnings Outlook Misses Estimates
コラムToday's Morning Movers and Top Ratings: NFLX, TSLA, ASML, DD and More
Gapping up
$ネットフリックス(NFLX.US)$ stock rose 9.4% after the streaming giant reported the addition of far more paying subscribers in the fourth quarter than expected, helped by a slate of popular programming.
$テスラ(TSLA.US)$ stock rose 1.3% after the EV manufacturer following a Reuters report which stated the company has informed suppliers it wants to start production of a new mass-market electric vehicle in mid-2025...
まだコメントはありません